Hypoxic incubator for physiological cell culture research

用于生理细胞培养研究的低氧培养箱

基本信息

  • 批准号:
    10427609
  • 负责人:
  • 金额:
    $ 10.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-20 至 2023-09-19
  • 项目状态:
    已结题

项目摘要

SUMMARY This proposal requests funds to acquire a hypoxic incubator and workstation in one, which provides precise control of temperature, humidity, oxygen and carbon dioxide levels. Oxygen levels can be controlled in 0.1% increments from 0.1% to 20%, thus encompassing the various levels found in tissues, including in tumors which often are extremely hypoxic with levels ranging between 0.3 and 2.0% oxygen. This application will directly support 6 NIH-funded investigators and 3 young investigators currently applying for NIH funding. Each of these investigators has specific projects that benefits from the unique aspects of the HypOxystation® H35 workstation. Cells that are under low oxygen tension accumulate and activate hypoxia-inducible transcription factor alpha- subunits HIF-1a and HIF-2a, leading to pleiotropic effects including modulating cellular metabolism, cell cycle and anti-inflammatory activities. Availability of this instrument will enable crucial investigations of the role of hypoxia in modulating the immunogenic effects of radiation, antigen presentation in cancer and diabetes, and mitochondrial dysfunction in autoimmunity. Unique features of the HypOxystation® H35, including a large workspace, sample input/output port, sleeve ports and precise environmental control and monitoring produce stable atmospheric conditions for culturing and manipulating samples, which is required for carrying out rigorous research into the role of oxygen tension within a biological system. The HypOxystation® H35 will provide capabilities to Weill Cornell Medicine and neighboring institutions and will be supervised by an advisory committee, overseen by the Radiation Oncology department, and will thus positively impact basic and translational NIH-funded research. The NIH-funded research programs supported by this instrumentation have relevance to cancer biology and treatment, immunology, metabolism, and autoimmunity.
总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sandra Demaria其他文献

Sandra Demaria的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sandra Demaria', 18)}}的其他基金

Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
分段放射激活癌细胞内源性干扰素-I 通路
  • 批准号:
    9207065
  • 财政年份:
    2016
  • 资助金额:
    $ 10.45万
  • 项目类别:
Individualized in situ vaccination by radiation and immunotherapy
通过放射和免疫治疗进行个体化原位疫苗接种
  • 批准号:
    9127533
  • 财政年份:
    2016
  • 资助金额:
    $ 10.45万
  • 项目类别:
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
分段放射激活癌细胞内源性干扰素-I 通路
  • 批准号:
    9009692
  • 财政年份:
    2016
  • 资助金额:
    $ 10.45万
  • 项目类别:
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
分段放射激活癌细胞内源性干扰素-I 通路
  • 批准号:
    10366757
  • 财政年份:
    2016
  • 资助金额:
    $ 10.45万
  • 项目类别:
Individualized in situ vaccination by radiation and immunotherapy
通过放射和免疫治疗进行个体化原位疫苗接种
  • 批准号:
    9904135
  • 财政年份:
    2016
  • 资助金额:
    $ 10.45万
  • 项目类别:
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
分段放射激活癌细胞内源性干扰素-I 通路
  • 批准号:
    10706961
  • 财政年份:
    2016
  • 资助金额:
    $ 10.45万
  • 项目类别:
Local Radiation as an Adjuvant for Immunotherapy
局部放射作为免疫治疗的辅助剂
  • 批准号:
    7263431
  • 财政年份:
    2007
  • 资助金额:
    $ 10.45万
  • 项目类别:
Local Radiation as an Adjuvant for Immunotherapy
局部放射作为免疫治疗的辅助剂
  • 批准号:
    7760656
  • 财政年份:
    2007
  • 资助金额:
    $ 10.45万
  • 项目类别:
Local Radiation as an Adjuvant for Immunotherapy
局部放射作为免疫治疗的辅助剂
  • 批准号:
    7383133
  • 财政年份:
    2007
  • 资助金额:
    $ 10.45万
  • 项目类别:
Local Radiation as an Adjuvant for Immunotherapy
局部放射作为免疫治疗的辅助剂
  • 批准号:
    8020091
  • 财政年份:
    2007
  • 资助金额:
    $ 10.45万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 10.45万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 10.45万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 10.45万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 10.45万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 10.45万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 10.45万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 10.45万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 10.45万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 10.45万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 10.45万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了